We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 84% in a year while the S&P 500 rose 12%.
“Sales for 2025 increased 8% to $1.854 billion, driven by new product ramps in targeted high-growth markets, higher demand across our base business”
| Latest filing | 8-K, Oct 29 |
After its last 4 reports it closed +1.1% on average, higher 2 of 4 times.
Below Averagefor quality, not price, 7 of 14 chart checks firingWhat the Quality Score means
ITGR is #67 of 84 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 67 |
Sales over four quarters against a year before: ITGR -0.3%, LIVN +12%.
Expected to report Thu Feb 25, before the open (in 107 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $449.7M, 4% less than a year ago; a profit of $0.43 a share, from $1.11.
“Cardio & Vascular sales decreased 5% to $263 million in the third quarter 2026 compared to the third quarter 2025, reflecting the previously communicated impact from the two new Electrophysiology products.”
| Line | Q3 2026 | Q2 2026 | Q3 2025 |
|---|---|---|---|
| Cardio and Vascular | $263M | $280M | $277M |
Each quarter's sales and their share of its total. Figures as filed (SEC filing, Oct 29)
No outlook figures read from this release.
“Growth was partially offset by the previously communicated impact from the one new Neuromodulation product.”
From its results filing (SEC filing · Oct 29)
Sales grew 12% a year over 5 years, fiscal 2020 to 2025.
Its share count grew 1.5% a year over 5 years.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Oct 29, 2026 | +0.0% | -0.0% | +0.1% |
| Aug 3, 2026 | +3.2% | +2.7% | +3.4% |
| Apr 30, 2026 | -7.9% | +5.8% | +3.1% |
| Feb 19, 2026 | +15.6% | -4.0% | +0.0% |
Sales grew in six of the last seven years, to $1.9B in 2025. It made a profit in each of the eight years.
RSI 59.4, MACD below signal, above both averages. Not scored.
2 insiders sold $5.2M across 3 filings in the last 6 months. No open-market buys on record. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: ITGR is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.
“We believe that very few companies offer the scope of manufacturing capabilities and services that we provide to medical device companies; however, we may compete in the future against other companies that provide broad manufacturing capabilities and related services.”
ITGR scores 0 today, which Breakaway calls Below Average. It is #67 of 84 in Medical Devices by Quality Score, with 7 of 14 chart checks firing. Up 84% in a year while the S&P 500 rose 12%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
ITGR scores 0 today, which Breakaway calls Below Average (0 to 5). That is #67 of 84 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind ITGR's 0.
2 insiders sold $5.2M across 3 filings in the last 6 months. No open-market buys on record. The newest is Kirk K. Thor, Chief Human Resources Officer, who sold $2.5M on Sep 14. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.